{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:42:44Z","timestamp":1792784564884,"version":"4.5.0"},"reference-count":34,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2025A0505020049"],"award-info":[{"award-number":["2025A0505020049"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005240","name":"Changjiang Scholar Program, Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024B1515040007"],"award-info":[{"award-number":["2024B1515040007"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"Youth Science Fund Project","doi-asserted-by":"publisher","award":["82404654"],"award-info":[{"award-number":["82404654"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004024","name":"Jinan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Project of Guangzhou National Laboratory","award":["GZNL2024A01011"],"award-info":[{"award-number":["GZNL2024A01011"]}],"id":[{"id":"https:\/\/ror.org\/03ybmxt82","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Activating NRAS mutations occur in approximately 20% of melanomas but remain largely undruggable due to the lack of effective targeted therapies. We previously identified casein kinase 1\u03b4 (CK1\u03b4) as a critical upstream regulator that stabilizes oncogenic NRAS mutants. However, no selective CK1\u03b4 inhibitors have advanced to clinical evaluation. Here, we report the discovery of 8u, a selective CK1\u03b4 degrader derived from PF-670462. Compound 8u potently degrades CK1\u03b4 in NRASQ61R melanoma cells (DC50 = 1.25 \u03bcM, Dmax = 74%) via the ubiquitin-proteasome system, sparing against the closely related isoform CK1\u03b1 and CK1\u03b5. CK1\u03b4 degradation induced by 8u leads to destabilization of NRASQ61R and attenuation of downstream signaling pathways. Furthermore, 8u elicited significant tumor regression (TGI = 58.9%) in an NRASQ61R xenograft model in vivo at 30 mg\/kg. The studies establish targeted degradation of CK1\u03b4 as a promising therapeutic strategy for NRAS-mutant melanoma.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01152","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:02:25Z","timestamp":1789758145000},"page":"23686-23705","source":"Crossref","is-referenced-by-count":0,"title":["Discovery and Synthesis of Selective Casein Kinase 1\u03b4 Degraders for Suppressing Oncogenic NRAS-Mutant Melanoma"],"prefix":"10.1021","volume":"69","author":[{"given":"Changfa","family":"Zhang","sequence":"first","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalei","family":"Wen","sequence":"additional","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiao","family":"Yi","sequence":"additional","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]},{"name":"The Affiliated Guangdong Second Provincial General Hospital of Jinan University , , , ,","place":["Guangzhou, Guangdong Province, China, 510317"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Pei","sequence":"additional","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Tu","sequence":"additional","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0730-9866","authenticated-orcid":true,"given":"Renwang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongzheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-6873","authenticated-orcid":true,"given":"Xiaoyun","family":"Lu","sequence":"additional","affiliation":[{"name":"Jinan University , , #855 Xingye Avenue , ,","place":["Guangzhou, China, 510632"]},{"name":"The Affiliated Guangdong Second Provincial General Hospital of Jinan University , , , ,","place":["Guangzhou, Guangdong Province, China, 510317"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"7","key":"2026102305085754500_cit1","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s43018-024-00794-1","article-title":"Determinants of Resistance and Response to Melanoma Therapy","volume":"5","author":"Robertson","year":"2024","journal-title":"Nat. Cancer"},{"issue":"1","key":"2026102305085754500_cit2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.advms.2014.12.002","article-title":"New Therapeutic Options for Advanced Non-Resectable Malignant Melanoma","volume":"60","author":"Stadler","year":"2015","journal-title":"Adv. Med. Sci."},{"issue":"4","key":"2026102305085754500_cit3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cps.2021.06.008","article-title":"Emerging Therapies in the Treatment of Advanced Melanoma","volume":"48","author":"Massand","year":"2021","journal-title":"Clin. Plast. Surg."},{"key":"2026102305085754500_cit4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/jamaoncol.2025.5751","article-title":"Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical Trial","volume":"12","author":"Sheng","year":"2026","journal-title":"JAMA Oncol."},{"issue":"3","key":"2026102305085754500_cit5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.20517\/cdr.2019.28","article-title":"Resistance Mechanisms in Melanoma to Immuneoncologic Therapy with Checkpoint Inhibitors","volume":"2","author":"Fenton","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"2026102305085754500_cit6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.20517\/element.2026.02","article-title":"The Arsenic Trioxide Paradox: A Targeted Therapy Triumph in APL versus a Metabolic Bottleneck Beyond","volume":"1","author":"Zhu","year":"2026","journal-title":"Elem."},{"issue":"20","key":"2026102305085754500_cit7","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1200\/jco.2011.41.2452","article-title":"BRAF\/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma","volume":"30","author":"Colombino","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"2026102305085754500_cit8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1470-2045(14)70051-8","article-title":"Vemurafenib in Patients with BRAF(V600) Mutated Metastatic Melanoma: An Open-Label, Multicentre, Safety Study","volume":"15","author":"Larkin","year":"2014","journal-title":"Lancet Oncol."},{"issue":"9839","key":"2026102305085754500_cit9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/s0140-6736(12)60868-x","article-title":"Dabrafenib in BRAF-Mutated Metastatic Melanoma: A Multicentre, Open-Label, Phase 3 Randomised Controlled Trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"issue":"4945","key":"2026102305085754500_cit10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1126\/science.2406906","article-title":"Molecular Switch for Signal Transduction: Structural Differences Between Active and Inactive Forms of Protooncogenic Ras Proteins","volume":"247","author":"Milburn","year":"1990","journal-title":"Sci."},{"issue":"1","key":"2026102305085754500_cit11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12895-017-0061-x","article-title":"Variation of Mutant Allele Frequency in NRAS Q61 Mutated Melanomas","volume":"17","author":"He\u0301lias-Rodzewicz","year":"2017","journal-title":"BMC Dermatol."},{"issue":"1","key":"2026102305085754500_cit12","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1038\/s41467-022-30881-9","article-title":"Enhanced BRAF Engagement by NRAS Mutants Capable of Promoting Melanoma Initiation","volume":"13","author":"Murphy","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"2026102305085754500_cit13","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1073\/pnas.1216013110","article-title":"Combined Targeting of MEK and PI3K\/mTOR Effector Pathways Is Necessary to Effectively Inhibit NRAS Mutant Melanoma in Vitro and in Vivo","volume":"110","author":"Posch","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7926","key":"2026102305085754500_cit14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-022-04838-3","article-title":"Structural Basis for SHOC2 Modulation of RAS Signalling","volume":"609","author":"Liau","year":"2022","journal-title":"Nat."},{"issue":"8066","key":"2026102305085754500_cit15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41586-025-08931-1","article-title":"Targeting the SHOC2\u2212RAS Interaction in RAS-Mutant Cancers","volume":"642","author":"Hauseman","year":"2025","journal-title":"Nat."},{"issue":"1","key":"2026102305085754500_cit16","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1038\/s41467-019-10367-x","article-title":"SHOC2 Phosphatase-Dependent RAF Dimerization Mediates Resistance to MEK Inhibition in RAS-Mutant Cancers","volume":"10","author":"Jones","year":"2019","journal-title":"Nat. Commun."},{"issue":"12","key":"2026102305085754500_cit17","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1039\/c002418j","article-title":"Small Molecule-Mediated Inhibition of Translation by Targeting a Native RNA G-Quadruplex","volume":"8","author":"Bugaut","year":"2010","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"2026102305085754500_cit18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nchembio864","article-title":"An RNA G-Quadruplex in the 5\u2032 UTR of the NRAS Proto-Oncogene Modulates Translation","volume":"3","author":"Kumari","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"2026102305085754500_cit19","doi-asserted-by":"publisher","first-page":"116406","DOI":"10.1016\/j.ejmech.2024.116406","article-title":"Design, Synthesis, and Evaluation of Novel Quindoline Derivatives with Fork-Shaped Side Chains as RNA G-Quadruplex Stabilizers for Repressing Oncogene NRAS Translation","volume":"271","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"2026102305085754500_cit20","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1021\/acs.jmedchem.3c00094","article-title":"Discovery of Clinically Used Octenidine as NRAS Repressor That Effectively Inhibits NRAS-Mutant Melanoma","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026102305085754500_cit21","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1021\/acs.jmedchem.5c03088","article-title":"Translational Suppression of KRAS and NRAS via RNA G-Quadruplex-Targeting Small Molecules for Colorectal Cancer Therapy","volume":"69","author":"Zheng","year":"2026","journal-title":"J. Med. Chem."},{"issue":"15","key":"2026102305085754500_cit22","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1021\/acs.jmedchem.8b00257","article-title":"Design, Synthesis, and Evaluation of Novel p-(Methylthio)Styryl Substituted Quindoline Derivatives as Neuroblastoma RAS (NRAS) Repressors via Specific Stabilizing the RNA G-Quadruplex","volume":"61","author":"Peng","year":"2018","journal-title":"J. Med. Chem."},{"issue":"6","key":"2026102305085754500_cit23","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1021\/acs.jmedchem.4c02314","article-title":"Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-Selective, Noncovalent Tri-Complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers","volume":"68","author":"Cregg","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026102305085754500_cit24","doi-asserted-by":"publisher","first-page":"10088","DOI":"10.1038\/s41467-024-54140-1","article-title":"Pharmacological Targeting of Casein Kinase 1\u03b4 Suppresses Oncogenic NRAS-Driven Melanoma","volume":"15","author":"Wen","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"2026102305085754500_cit25","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1021\/jm201387s","article-title":"Structural Basis for the Interaction between Casein Kinase 1 Delta and a Potent and Selective Inhibitor","volume":"55","author":"Long","year":"2012","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026102305085754500_cit26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.bbrc.2019.12.105","article-title":"IC261 Suppresses Progression of Hepatocellular Carcinoma in a Casein Kinase 1 \u03b4\/\u03b5 Independent Manner","volume":"523","author":"Yuan","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"2026102305085754500_cit27","doi-asserted-by":"publisher","first-page":"F918","DOI":"10.1152\/ajprenal.00678.2011","article-title":"Inhibition of \u03b1ENaC Expression and ENaC Activity Following Blockade of the Circadian Clock-Regulatory Kinases CK1\u03b4\/\u03b5","volume":"303","author":"Richards","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"2026102305085754500_cit28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1471-4159.2011.07308.x","article-title":"Casein Kinase 1 Enables Nucleus Accumbens Amphetamine-Induced Locomotion by Regulating AMPA Receptor Phosphorylation","volume":"118","author":"Li","year":"2011","journal-title":"J. Neurochem."},{"issue":"11","key":"2026102305085754500_cit29","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202217532","article-title":"Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity","volume":"62","author":"Ne\u030cmec","year":"2023","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026102305085754500_cit30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/acsmedchemlett.3c00523","article-title":"Structure-Based Optimization of Selective and Brain Penetrant CK1\u03b4 Inhibitors for the Treatment of Circadian Disruptions","volume":"15","author":"McCarver","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"2026102305085754500_cit31","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1021\/acs.jmedchem.2c01180","article-title":"Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1\u03b5 vs Casein Kinase 1\u03b4","volume":"66","author":"Choi","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026102305085754500_cit32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1021\/acs.jmedchem.4c02201","article-title":"Development and Discovery of a Selective Degrader of Casein Kinases 1 \u03b4\/\u03b5","volume":"68","author":"Haag","year":"2025","journal-title":"J. Med. Chem."},{"issue":"22","key":"2026102305085754500_cit33","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.3390\/molecules30224452","article-title":"Design and Synthesis of Novel Candidate CK1\u03b4 Proteolysis Targeting Chimeras (PROTACs)","volume":"30","author":"Arnold","year":"2025","journal-title":"Molecules"},{"issue":"15","key":"2026102305085754500_cit34","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1016\/j.bmcl.2013.05.075","article-title":"Development of Highly Selective Casein Kinase 1\u03b4\/1\u03b5 (CK1\u03b4\/\u03b5) Inhibitors with Potent Antiproliferative Properties","volume":"23","author":"Bibian","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01152","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23686\/68559634\/jm6c01152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23686\/68559634\/jm6c01152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:31:03Z","timestamp":1792747863000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/23686\/5433010\/Discovery-and-Synthesis-of-Selective-Casein-Kinase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":34,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,9,18]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01152","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}